Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
need to insulate patients from outside influences or choose outcomes which cannot<br />
plausibly be affected by external factors. This is most evident when therapies span several<br />
years as in those for thermal burns and acute myocardial infarction.<br />
Regression to the mean<br />
Regression to the mean occurs in studies that have asymmetrically sampled from the<br />
population A result of this sampling effect is regression of the sample mean toward the<br />
population mean from pre- to post-test. For example, patients who exhibit a randomly<br />
high score at the beginning of a trial will show a lower value post intervention and<br />
patients with extremely low scores will present with higher scores at the end of the trial.<br />
A selection regression threat can also occur when the intervention and control groups are<br />
not comparable. For example, if the HBOT group had a disproportionate number of<br />
subjects with extremely high values compared to controls we would expect the HBOT<br />
group to regress a greater distance towards the overall population mean. The HBOT<br />
group would therefore appear to have better outcomes than controls. Under these<br />
circumstances it would be wrong to attribute such differential change to HBOT since it<br />
may be a result of statistical regression. Comparative studies in cluster headaches and<br />
sudden deafness might be predisposed to this threat.<br />
Placebo effect<br />
The placebo effect arises from the tendency of individuals to report a favourable<br />
response regardless of the physiological efficacy of treatment. For studies that do not use<br />
a placebo control group it is impossible to determine whether subjective outcomes are<br />
due to the treatment effect or to other factors such as differential treatment of the study<br />
group or the patients’ belief that the treatment is beneficial. Blinding is also necessary to<br />
negate the placebo effect. Participants in a trial may change their behaviour (change of<br />
lifestyle or withdraw from the study) in a systematic way if they are aware of which group<br />
they have been allocated. This also applies to researchers who may change their<br />
treatment practices for patients in the group that is presumed to produce a more or less<br />
favourable result depending on their hypothesis. Therefore the use of a placebo group<br />
with blinding will ensure that all aspects of the intervention offered to patients are<br />
identical except for the actual experimental treatment.<br />
Maturation<br />
The effect of maturation can arise from differential rates of normal growth between preand<br />
post-test. Thus the changes that would occur as a result of the ongoing<br />
developmental process (such as healing and mortality) may be confused with the impact<br />
of treatment. In the event that intervention and control groups are maturing at different<br />
rates, with respect to outcome, it cannot be assumed that post-test differences are a result<br />
of treatment.<br />
Testing effects<br />
A testing effect can be the result of familiarity from repeated testing. Patients can modify<br />
their responses or behaviour in order to achieve more favourable test results. The extent<br />
to which this validity threat applies to HBOT is small since the majority of outcomes<br />
were objective measures.<br />
<strong>Hyperbaric</strong> oxygen therapy 79